• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Piper Sandler Companies

    5/21/26 12:45:04 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance
    Get the next $PIPR alert in real time by email
    S-8 1 tm2614959d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on May 21, 2026

     

    Registration No. 333-

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-8
    REGISTRATION STATEMENT

    UNDER THE

    SECURITIES ACT OF 1933

     

     

    Piper SANDLER Companies

    (Exact name of registrant as specified in its charter)

     

    Delaware       30-0168701
    (State or other jurisdiction of
    incorporation or organization)

    350 North 5th Street, Suite 1000
    Minneapolis, Minnesota

    (Address of Principal Executive
    Offices)  
            (I.R.S. Employer
    Identification No.)

    55401
    (Zip Code)

     

     

    PIPER SANDLER COMPANIES AMENDED AND RESTATED
    2003 ANNUAL AND LONG-TERM INCENTIVE PLAN

    (as amended and restated May 17, 2023)

    (Full title of the plan)

     

     

    John W. Geelan

    General Counsel and Secretary

    Piper Sandler Companies

    350 North 5th Street, Suite 1000

    Minneapolis, Minnesota 55401

    (Name and address of agent for service)

     

    (612) 303-6000

    (Telephone number, including area code, of agent for service)

     

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer x   Accelerated filer ¨
    Non-accelerated filer ¨   Smaller reporting company ¨
        Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed for the purpose of registering an additional 3,087,152 shares of common stock, par value $0.01 per share (the “Common Stock”), of Piper Sandler Companies, a Delaware corporation (the “Registrant”), to be issued pursuant to the Piper Sandler Companies Amended and Restated 2003 Annual and Long-Term Incentive Plan (as amended and restated May 17, 2023) (the “Plan”). In accordance with Section E of the General Instructions to Form S-8, the contents of the following Registration Statements on Form S-8 relating to the Plan previously filed with the Securities and Exchange Commission (the “Commission”) are incorporated herein by reference File No. 333-111665, File No. 333-122494, File No. 333-142699, File No. 333-150962, File No. 333-159360, File No. 333-205229, File No. 333-228096, File No. 333-238598, File No. 333-268089, and File No. 333-272072.

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 8.Exhibits.

     

    The following are filed as exhibits to this Registration Statement:

     

    EXHIBIT INDEX

     

    Exhibit
    No.
      Description   Method of Filing
    4.1   Amended and Restated Certificate of Incorporation of Piper Sandler Companies   (1)
             
    4.2   Certificate of Amendment of Amended and Restated Certificate of Incorporation of Piper Sandler Companies   (2)
             
    4.3   Amended and Restated Bylaws of Piper Sandler Companies (as of February 9, 2023)   (3)
             
    4.4   Form of Specimen Certificate for Piper Sandler Companies Common Stock   (4)
             
    4.5   Piper Sandler Companies Amended and Restated 2003 Annual and Long-Term Incentive Plan (as amended and restated May 17, 2023)   (5)
             
    5.1   Opinion of Faegre Drinker Biddle & Reath LLP   Filed herewith
             
    23.1   Consent of Ernst & Young LLP   Filed herewith
             
    23.2   Consent of Faegre Drinker Biddle & Reath LLP   Included in Exhibit 5.1
             
    24.1   Power of Attorney   Filed herewith
             
    107   Filing Fee Table   Filed herewith
             
    (1)   Filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Commission on May 18, 2023, and incorporated herein by reference.
    (2)   Filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Commission on March 23, 2026, and incorporated herein by reference.
    (3)   Filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Commission on February 10, 2023, and incorporated herein by reference.
    (4)   Filed as Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Commission on February 26, 2018, and incorporated herein by reference.
    (5)   Filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed with the Commission on May 18, 2023, and incorporated herein by reference.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minneapolis, State of Minnesota, on May 21, 2026.

     

     

    PIPER SANDLER COMPANIES

    (Registrant)

         
      By: /s/ Chad R. Abraham
       

    Name: Chad R. Abraham

    Title: Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

     

    SIGNATURE   TITLE   DATE
             
    /s/ Chad R. Abraham   Chairman and Chief Executive Officer   May 21, 2026
    Chad R. Abraham   (Principal Executive Officer)    
             
    /s/ Katherine P. Clune   Chief Financial Officer   May 21, 2026
    Katherine P. Clune   (Principal Financial Officer and Principal Accounting Officer)    
             
    *   Director   May 21, 2026
    Jonathan J. Doyle        
             
    *   Director   May 21, 2026
    Stuart M. Essig        
             
    *   Director   May 21, 2026
    Ann C. Gallo        
             
    *   Director   May 21, 2026
    Victoria M. Holt        
             
    *   Director   May 21, 2026
    Robbin Mitchell        

     

     

     

     

    *   Director   May 21, 2026
    Thomas S. Schreier, Jr.        

     

    *   Director   May 21, 2026
    Philip E. Soran        

     

    *   Director   May 21, 2026
    Brian R. Sterling        

     

    *   Director   May 21, 2026
    Scott C. Taylor        

     

    *   John W. Geelan, by signing his name hereto, does sign this document on behalf of the above noted individuals, pursuant to the powers of attorney duly executed by such individuals which have been filed as an exhibit to this Registration Statement.

     

      By: /s/ John W. Geelan
        Name: John W. Geelan
        Title: Attorney-in-Fact

     

     

     

    Get the next $PIPR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PIPR

    DatePrice TargetRatingAnalyst
    3/4/2026$350.00Market Perform → Outperform
    Northland Capital
    1/26/2026$385.00Underperform
    BofA Securities
    11/10/2025$386.00Neutral → Buy
    Goldman
    7/10/2025$339.00Peer Perform → Outperform
    Wolfe Research
    1/6/2025$317.00Buy → Neutral
    Goldman
    1/10/2024Mkt Outperform → Mkt Perform
    JMP Securities
    12/19/2023Outperform → Market Perform
    Northland Capital
    7/11/2022$132.00Outperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $PIPR
    SEC Filings

    View All

    Piper Sandler Companies filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - PIPER SANDLER COMPANIES (0001230245) (Filer)

    5/21/26 2:08:54 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    SEC Form S-8 filed by Piper Sandler Companies

    S-8 - PIPER SANDLER COMPANIES (0001230245) (Filer)

    5/21/26 12:45:04 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by Piper Sandler Companies

    10-Q - PIPER SANDLER COMPANIES (0001230245) (Filer)

    5/7/26 12:32:59 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

    Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and MedtronicParticipation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture FundsProceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercializationBoard strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representin

    6/4/26 6:34:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper Sandler's financial sponsor group. "Rob and Tripp are each well-respected, creative bankers with proven track records. They have played a large role in the growth of the services & industrials group over the past several years. We loo

    6/2/26 9:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

    Industry veterans John Mori and Eric Friel to lead new group Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distressed assets, trade and insurance claims, reorganized equity and other securities issued by companies facing financial stress, including default or bankruptcy. Add

    5/11/26 9:01:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler upgraded by Northland Capital with a new price target

    Northland Capital upgraded Piper Sandler from Market Perform to Outperform and set a new price target of $350.00

    3/4/26 8:30:06 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    BofA Securities initiated coverage on Piper Sandler with a new price target

    BofA Securities initiated coverage of Piper Sandler with a rating of Underperform and set a new price target of $385.00

    1/26/26 10:01:23 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler upgraded by Goldman with a new price target

    Goldman upgraded Piper Sandler from Neutral to Buy and set a new price target of $386.00

    11/10/25 8:37:23 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Global Co-Head IB and Cap Mkts Baker James P bought $534,640 worth of shares (2,000 units at $267.32), increasing direct ownership by 3% to 59,867 units (SEC Form 4)

    4/A - PIPER SANDLER COMPANIES (0001230245) (Issuer)

    5/21/25 5:47:50 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taylor Scott C was granted 1,875 shares, increasing direct ownership by 3% to 67,927 units (SEC Form 4)

    4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)

    5/21/26 4:13:11 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Director Sterling Brian R was granted 1,875 shares, increasing direct ownership by 2% to 104,534 units (SEC Form 4)

    4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)

    5/21/26 4:12:05 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Director Soran Philip was granted 1,875 shares, increasing direct ownership by 2% to 81,082 units (SEC Form 4)

    4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)

    5/21/26 4:11:09 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Piper Sandler Companies (Amendment)

    SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)

    2/13/24 5:12:08 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Piper Sandler Companies (Amendment)

    SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)

    2/9/23 11:30:21 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Piper Sandler Companies (Amendment)

    SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)

    7/11/22 1:13:14 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Financials

    Live finance-specific insights

    View All

    Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

    Piper Sandler Companies (NYSE:PIPR) has released its most recent financial results. The complete earnings release can be found on the firm's website at pipersandler.com/earnings. Join the earnings conference call on Friday, May 1, 2026 at 7:30 a.m. CT. Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) Passcode: 5642050 Access the conference call audio webcast. A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE:PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment bankin

    5/1/26 7:30:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Companies to Announce First Quarter 2026 Financial Results and Host a Conference Call on May 1, 2026

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, will release its first quarter 2026 financial results prior to the opening of the market on Friday, May 1, 2026. The earnings release will be available at the company's website at pipersandler.com/earnings. Chad Abraham, chairman and chief executive officer; Deb Schoneman, president; and Kate Clune, chief financial officer, will host a related conference call at 8:30 a.m. ET (7:30 a.m. CT) that same day to review the financial results. There will be a question and answer session following the review. Investors and analysts may participate in the live conference call by dialing 800 330-6710 (in the U.S.) or +1 312 471-1353 (

    4/21/26 12:00:00 PM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Companies Reports Fourth Quarter and Full Year 2025 Results; Declares Special Dividend of $5.00 Per Share and Quarterly Dividend of $0.70 Per Share; Announces 4-for-1 Stock Split

    Piper Sandler Companies (NYSE:PIPR) has released its most recent financial results. The complete earnings release can be found on the firm's website at pipersandler.com/earnings. Join the earnings conference call on Friday, February 6, 2026, at 7:00 a.m. CT. Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) Passcode: 3387875. Access the conference call audio webcast. A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event. For additional information on the stock split, please visit the Shareholder Information page on our website. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE:PIPR) is a leadin

    2/6/26 7:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    $PIPR
    Leadership Updates

    Live Leadership Updates

    View All

    Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper Sandler's financial sponsor group. "Rob and Tripp are each well-respected, creative bankers with proven track records. They have played a large role in the growth of the services & industrials group over the past several years. We loo

    6/2/26 9:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. "We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising biopharma companies across the full spectrum of equity and M&A transactions, combined with his rare scientific and clinical perspective, makes him an exceptional addition to our group. Patrick's extensive relationships with management teams, boards o

    4/27/26 9:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. "Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue expanding our capabilities in this important and evolving space," said J.P. Peltier, global co-head of investment banking and capital markets. "I'm honored to step into this new role and excited to work alongside our talented te

    2/25/26 9:00:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance